Novartis is shelling out $1 billion upfront to buy a Watertown startup that's working to make radiation treatment more ...

The phase 3 CONVERT study suggests that twice-daily radiotherapy remains the standard for limited-stage small cell lung ...

The $1 billion dollar acquisition will add to Novartis’ pipeline of the targeted radiation drugs, giving it a potential lung cancer treatment.

BIO 300 use led to reduced levels of a proinflammatory/profibrotic cytokine associated with lung injury from radiation ...

“Lung cancer encompasses two primary categorizations: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC),” ...

Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that ...

The current list includes development candidate MC-339, an actinium-based RLT being investigated in small cell lung cancer. RLTs are a type of ... This targeted delivery of radiation helps limit ...

The study, led by principal investigator Nitin Ohri, M.D., a professor in Radiation Oncology at the Montefiore Einstein Comprehensive Cancer Center, aims to demonstrate the feasibility of PGHD ...

Definitive treatment to the primary site improves overall and cancer-specific survival among patients with brain-only NSCLC ...

Despite significant progress in treating gastrointestinal (GI) cancers through surgical resection, chemotherapy, radiotherapy ...

Welcome to the NovoCure Q1 2024 earnings conference call. [Operator instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your ...

Smoking cessation is associated with improved treatment responses, reduced side effects, lower risks of secondary cancers, and increased overall survival.